Financials

  • Market Capitalization 71.04 M
  • Employee 87
  • Founded 2005
  • CEO N/A
  • Website www.xbiotech.com
  • Headquarter British Columbia, Canada
  • FIGI BBG0081S8D39
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.6
Price to sales ratio
21.86

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4129
GANX
Gain Therapeutics, Inc. - Common Stock
1.76 USD-2.22%-2.76%+2.92%-5.38%75.07 M USD
4152
IBIO
iBio, Inc. - Common Stock
1.45 USD-3.97%-12.12%-15.20%-36.96%72.03 M USD
4156
PLRX
Pliant Therapeutics, Inc. - Common Stock
1.14 USD+1.79%-0.87%-1.72%-21.38%70.59 M USD
4166
IMA
ImageneBio, Inc. - Common Stock
6.11 USD+3.38%+2.52%+5.34%-66.06%68.92 M USD

Frequently asked questions about XBiotech Inc. - Common Stock

What is the XBiotech Inc. - Common Stock stock price today?

The current price of XBiotech Inc. - Common Stock (XBIT) is 2.33. Over the past 24 hours, the stock has changed by +1.75%. Follow the XBIT chart for real-time price dynamics.

What is the stock ticker of XBiotech Inc. - Common Stock?

XBiotech Inc. - Common Stock trades under the ticker XBIT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is XBiotech Inc. - Common Stock stock going up?

XBIT has changed by -2.10% over the last week, -1.69% over the last month, and -19.66% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does XBiotech Inc. - Common Stock release financial reports?

Yes. You can track XBiotech Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was XBiotech Inc. - Common Stock net income for the last quarter?

XBiotech Inc. - Common Stock reported net income of -5.5 M for the last quarter. The previous quarter showed -26.89 M, which means net income changed by +79.53%.

How many employees does XBiotech Inc. - Common Stock have?

As of the latest available data, XBiotech Inc. - Common Stock has 87 employees. Workforce size can provide additional context about the company's scale and operations.

What is XBiotech Inc. - Common Stock EBITDA?

XBiotech Inc. - Common Stock EBITDA is -1.87 M, and its EBITDA margin is 165.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy XBiotech Inc. - Common Stock stock?

You can buy XBiotech Inc. - Common Stock (XBIT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in XBiotech Inc. - Common Stock stock?

Investing in XBiotech Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XBIT chart and related analysis on metatrader.com as part of your research.

XBiotech Inc. - Common Stock

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

News